Mitiglinide (calcium)
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Mitiglinide (calcium)
Description:
Mitiglinide Calcium (KAD-1229 anhydrous), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide Calcium is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel) . Mitiglinide Calcium can be used for the research of type 2 diabetes[1][2].Product Name Alternative:
KAD-1229 (anhydrous) ; S21403 (anhydrous)UNSPSC:
12352211Hazard Statement:
H302, H315, H319, H335Target:
Potassium ChannelType:
Reference compoundRelated Pathways:
Membrane Transporter/Ion ChannelApplications:
Metabolism-protein/nucleotide metabolismField of Research:
Metabolic DiseaseAssay Protocol:
https://www.medchemexpress.com/Mitiglinide-Calcium.htmlPurity:
98.82Solubility:
DMSO : 5 mg/mL (ultrasonic)Smiles:
O=C([O-])[C@H](CC(N1C[C@](CCCC2)([H])[C@]2([H])C1)=O)CC3=CC=CC=C3.[0.5Ca2+]Molecular Formula:
C19H24NO3.1/2CaMolecular Weight:
334.44Precautions:
H302, H315, H319, H335References & Citations:
[1]Y Sunaga, et al. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide. Eur J Pharmacol. 2001 Nov 9;431 (1) :119-25.|[2]Kiyoshi Ichikawa, et al. Effect of KAD-1229, a novel hypoglycaemic agent, on plasma glucose levels after meal load in type 2 diabetic rats. Clin Exp Pharmacol Physiol. May-Jun 2002;29 (5-6) :423-7.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, sealed storage, away from moisture)Scientific Category:
Reference compound1Clinical Information:
LaunchedCAS Number:
[145525-41-3]
